Publications
18 results found
Orlovic M, Ahmad A, Saunders BP, 2023, Economic impact of implementing optical diagnosis with a "resect and discard" strategy within the English Bowel Cancer Screening Programme: findings from the DISCARD3 study, GASTROINTESTINAL ENDOSCOPY, Vol: 98, Pages: 73-82, ISSN: 0016-5107
- Author Web Link
- Cite
- Citations: 1
Magni T, Ragni C, Pelizzi N, et al., 2023, Health Economic Studies of Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome: A Systematic Literature Review, PHARMACOECONOMICS-OPEN, ISSN: 2509-4262
Colucciello A, Magni T, Ragni C, et al., 2022, A SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC BURDEN OF SURFACTANT USE IN THE TREATMENT OF NEONATES WITH RESPIRATORY DISTRESS SYNDROME, Publisher: ELSEVIER SCIENCE INC, Pages: S486-S486, ISSN: 1098-3015
Orlovic M, Mossialos E, Orkaby AR, et al., 2022, Challenges for Patients Dying of Heart Failure and Cancer, CIRCULATION-HEART FAILURE, Vol: 15, Pages: 1069-1079, ISSN: 1941-3289
- Author Web Link
- Cite
- Citations: 1
Orlovic M, Magni T, Lukyanov V, et al., 2022, Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/ formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England, RESPIRATORY MEDICINE, Vol: 201, ISSN: 0954-6111
Zadeh AD, Lewis H, Orlovic M, 2022, HEALTHCARE RESOURCE AND FINANCIAL IMPLICATIONS OF AN ENVIRONMENTALLY DRIVEN SWITCH IN RESPIRATORY INHALER USE IN THE ENGLISH NHS, Publisher: ELSEVIER SCIENCE INC, Pages: S166-S166, ISSN: 1098-3015
Kaur G, Verma M, Sharma S, et al., 2022, A SYSTEMATIC LITERATURE REVIEW OF THE CLINICAL EFFICACY OF TRIPLE THERAPY FOR MODERATE TO SEVERE COPD PATIENTS, Publisher: ELSEVIER SCIENCE INC, Pages: S31-S31, ISSN: 1098-3015
Jhanjee R, Verma M, Sharma S, et al., 2022, A SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC BURDEN OF TRIPLE THERAPY FOR MODERATE TO SEVERE COPD, Publisher: ELSEVIER SCIENCE INC, Pages: S90-S91, ISSN: 1098-3015
Orlovic M, Warraich H, Wolf D, et al., 2021, End-of-Life Planning Depends on Socio-Economic and Racial Background: Evidence from the US Health and Retirement Study (HRS), JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, Vol: 62, Pages: 1198-1206, ISSN: 0885-3924
- Author Web Link
- Cite
- Citations: 2
Attar-Zadeh D, Lewis H, Orlovic M, 2021, Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England, JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, Vol: 8, Pages: 46-54, ISSN: 2327-2236
- Author Web Link
- Cite
- Citations: 4
Orlovic M, Callender T, Riley J, et al., 2020, Impact of advance care planning on dying in hospital: Evidence from urgent care records, PLoS One, Vol: 15, Pages: 1-12, ISSN: 1932-6203
Place of death is an important outcome of end-of-life care. Many people do not have the opportunity to express their wishes and die in their preferred place of death. Advance care planning (ACP) involves discussion, decisions and documentation about how an individual contemplates their future death. Recording end-of-life preferences gives patients a sense of control over their future. Coordinate My Care (CMC) is London’s largest electronic palliative care register designed to provide effective ACP, with information being shared with urgent care providers. The aim of this study is to explore determinants of dying in hospital. Understanding advance plans and their outcomes can help in understanding the potential effects that implementation of electronic palliative care registers can have on the end-of-life care provided. Retrospective observational cohort analysis included 21,231 individuals aged 18 or older with a Coordinate My Care plan who had died between March 2011 and July 2019 with recorded place of death. Logistic regression was used to explore demographic and end-of-life preference factors associated with hospital deaths. 22% of individuals died in hospital and 73% have achieved preferred place of death. Demographic characteristics and end-of-life preferences have impact on dying in hospital, with the latter having the strongest influence. The likelihood of in-hospital death is substantially higher in patients without documented preferred place of death (OR = 1.43, 95% CI 1.26–1.62, p<0.001), in those who prefer to die in hospital (OR = 2.30, 95% CI 1.60–3.30, p<0.001) and who prefer to be cared in hospital (OR = 2.77, 95% CI 1.94–3.96, p<0.001). “Not for resuscitation” individuals (OR = 0.43, 95% CI 0.37–0.50, p<0.001) and who preferred symptomatic treatment (OR = 0.36, 95% CI 0.33–0.40, p<0.001) had a lower likelihood of in-hospital death. Effective advance care planning is necessary for improve
Orlovic M, Riley J, Droney J, 2020, Impact of advance care planning on the place of death for cancer patients: A retrospective cohort study., Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Publisher: LIPPINCOTT WILLIAMS & WILKINS, ISSN: 0732-183X
Viscidi E, Morris H, Harrington A, et al., 2020, The epidemiology of progressive supranuclear palsy in the United Kingdom: evidence from the Clinical Practice Research Datalink GP Online Database (CPRD GOLD), 6th Congress of the European-Academy-of-Neurology (EAN), Publisher: WILEY, Pages: 67-67, ISSN: 1351-5101
- Author Web Link
- Cite
- Citations: 1
Orlovic M, 2019, UNDERSTANDING TRENDS IN DEMENTIA AND COGNITIVE IMPAIRMENT IN THE UNITED STATES: EVIDENCE FROM THE HEALTH AND RETIREMENT STUDY (HRS), Publisher: ELSEVIER SCIENCE INC, Pages: S231-S231, ISSN: 1098-3015
Orlovic M, Smith K, Mossialos E, 2019, Racial and ethnic differences in end-of-life care in the United States: Evidence from the Health and Retirement Study (HRS), SSM-POPULATION HEALTH, Vol: 7, ISSN: 2352-8273
- Author Web Link
- Cite
- Citations: 76
Orlovic M, Marti J, Mossialos E, 2017, Analysis Of End-Of-Life Care, Out-Of-Pocket Spending, And Place Of Death In 16 European Countries And Israel, HEALTH AFFAIRS, Vol: 36, Pages: 1201-1210, ISSN: 0278-2715
- Author Web Link
- Cite
- Citations: 23
Orlovic M, Carter AW, Marti J, et al., 2017, Estimating the incidence and the economic burden of third and fourth-degree obstetric tears in the English NHS: an observational study using propensity score matching, BMJ Open, Vol: 7, ISSN: 2044-6055
Objective Obstetric care is a high-risk area in healthcaredelivery, so it is essential to have up-to-date quantitativeevidence in this area to inform policy decisions regardingthese services. In light of this, the objective of this studyis to investigate the incidence and economic burden ofthird and fourth-degree lacerations in the English NationalHealth Service (NHS) using recent national data.Methods We used coded inpatient data from HospitalEpisode Statistics (HES) for the financial years from2010/2011 to 2013/2014 for all females that gave birthduring that period in the English NHS. Using HES, we usedpre-existing safety indicator algorithms to calculate theincidence of third and fourth-degree obstetric tears andemployed a propensity score matching method to estimatethe excess length of stay and economic burden associatedwith these events.Results Observed rates per 1000 inpatient episodes in2010/2011 and 2013/2014, respectively: Patient SafetyIndicator—trauma during vaginal delivery with instrument(PSI 18)=84.16 and 91.24; trauma during vaginaldelivery without instrument (PSI 19)=29.78 and 33.43;trauma during caesarean delivery (PSI 20)=3.61 and4.56. Estimated overall (all PSIs) economic burden for2010/2011=£10.7 million and for 2013/2014=£14.5million, expressed in 2013/2014 prices.Conclusions Despite many initiatives targeting thequality of maternity care in the NHS, the incidence of thirdand fourth-degree lacerations has increased during theobserved period which signals that quality improvementefforts in obstetric care may not be reducing incidencerates. Our conservative estimates of the financial burden ofthese events appear low relative to total NHS expenditurefor these years.
Orlovic M, 2013, Test of the Validity of Refund and Calculation of the Indemnification to Pensioners, REVIJA ZA SOCIJALNU POLITIKU, Vol: 20, Pages: 315-324, ISSN: 1330-2965
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.